ArticleJournal for immunotherapy of cancer2023

Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx.

Shipra Gandhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.